NASDAQ:SWKH - SWK Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $23.00
  • Forecasted Upside: 67.27 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$13.75
▲ +0.07 (0.51%)
1 month | 3 months | 12 months
Get New SWK Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SWKH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SWKH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$23.00
▲ +67.27% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for SWK in the last 3 months. The average price target is $23.00, with a high forecast of $23.00 and a low forecast of $23.00. The average price target represents a 67.27% upside from the last price of $13.75.
Buy
The current consensus among 2 polled investment analysts is to buy stock in SWK.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/7/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/5/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/3/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/30/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/29/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/3/2020Maxim GroupInitiated CoverageBuy$23.00Low
i
5/27/2020Dougherty & CoReiterated RatingBuyHigh
i
Rating by K. Bauser at Dougherty & Co
5/27/2020Dougherty & CoInitiated CoverageBuy$23.00Medium
i
(Data available from 2/28/2016 forward)
SWK logo
SWK Holdings Corporation, a specialized finance company, focuses on the healthcare sector. The company operates through two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The company also engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endometriosis; and Tobrate, an oral tobramycin tablet for the treatment of uncomplicated urinary tract infections. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $13.75
$13.75
$14.39

50 Day Range

MA: $14.04
$13.16
$15.07

52 Week Range

Now: $13.75
$6.12
$16.24

Volume

9,216 shs

Average Volume

9,337 shs

Market Capitalization

$175.85 million

P/E Ratio

18.84

Dividend Yield

N/A

Beta

0.18

Frequently Asked Questions

What sell-side analysts currently cover shares of SWK?

The following sell-side analysts have issued research reports on SWK in the last year: Dougherty & Co, Maxim Group, and Zacks Investment Research.
View the latest analyst ratings for SWKH.

What is the current price target for SWK?

2 Wall Street analysts have set twelve-month price targets for SWK in the last year. Their average twelve-month price target is $23.00, suggesting a possible upside of 67.3%. Dougherty & Co has the highest price target set, predicting SWKH will reach $23.00 in the next twelve months. Dougherty & Co has the lowest price target set, forecasting a price of $23.00 for SWK in the next year.
View the latest price targets for SWKH.

What is the current consensus analyst rating for SWK?

SWK currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SWKH will outperform the market and that investors should add to their positions of SWK.
View the latest ratings for SWKH.

What other companies compete with SWK?

How do I contact SWK's investor relations team?

SWK's physical mailing address is 14755 PRESTON ROAD SUITE 105, DALLAS TX, 75254. The company's listed phone number is 972-687-7250 and its investor relations email address is [email protected] The official website for SWK is www.swkhold.com.